HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Histopathologic and clinical features of medullary microcarcinoma and C-cell hyperplasia in prophylactic thyroidectomies for medullary carcinoma: a study of 42 cases.

AbstractCONTEXT:
Prophylactic thyroidectomies are increasingly performed on patients at risk for developing medullary thyroid carcinoma (MTC); consequently, pathologists are more commonly encountering these specimens in routine practice.
OBJECTIVE:
To describe the detailed clinicopathologic features of prophylactic thyroidectomies for medullary carcinoma.
DESIGN:
We present a retrospective series of 42 prophylactic thyroidectomies for MTC performed for one or more of the following: family history of multiple endocrine neoplasia (MEN) or MTC, elevated serum calcitonin level, or detection of a RET proto-oncogene mutation.
RESULTS:
Patients included 22 men and 20 women (mean age, 26.2 years). Among those with known RET proto-oncogene mutations, affected sites included exons 10, 11, 14, and 16. In 93% (n = 39) of cases, either C-cell hyperplasia (n = 36), medullary microcarcinoma (MMC; n = 29), or medullary macrocarcinoma (n = 1) was found. C-cell hyperplasia was often multifocal (n = 30) and bilateral (n = 23) and included both nonnodular and nodular patterns. A total of 94% of C-cell hyperplasia cases and all MMC cases were microscopically detectable using hematoxylin-eosin stains. The MMCs were characterized by a complex microarchitectural pattern with a desmoplastic stromal response (n = 29) and focal amyloid deposition (n = 12). Most MMCs exhibited a solid pattern (n = 24) of round, polygonal, spindled, or plasmacytoid-shaped cells. Only 1 case of MMC showed evidence of metastatic disease to a pretracheal lymph node.
CONCLUSIONS:
Based upon our clinicopathologic findings and review of the literature, we conclude that thyroidectomies in at-risk patients are very frequently associated with C-cell hyperplasia and/or MMC; however, the clinical prognosis for these patients is very good.
AuthorsDemet Etit, William C Faquin, Randall Gaz, Gregory Randolph, Ronald A DeLellis, Ben Z Pilch
JournalArchives of pathology & laboratory medicine (Arch Pathol Lab Med) Vol. 132 Issue 11 Pg. 1767-73 (Nov 2008) ISSN: 1543-2165 [Electronic] United States
PMID18976013 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • MAS1 protein, human
  • Proto-Oncogene Mas
  • Calcitonin
  • Proto-Oncogene Proteins c-ret
Topics
  • Adolescent
  • Adult
  • Aged
  • Calcitonin (blood)
  • Carcinoma, Medullary (pathology, prevention & control, surgery)
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Hyperplasia (pathology)
  • Lymph Nodes (pathology)
  • Male
  • Middle Aged
  • Mutation (genetics)
  • Parathyroid Glands (pathology)
  • Proto-Oncogene Mas
  • Proto-Oncogene Proteins c-ret (genetics)
  • Retrospective Studies
  • Thyroid Gland (pathology, surgery)
  • Thyroid Neoplasms (pathology, prevention & control, surgery)
  • Thyroidectomy

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: